Unravelling the role of beta-catenin in ground state pluripotency
揭示β-连环蛋白在基态多能性中的作用
基本信息
- 批准号:MR/N021444/1
- 负责人:
- 金额:$ 51.55万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Stem cells are defined by two properties: they can proliferate indefinitely producing cells identical to themselves (self-renewal property), and can specialise (differentiate) into mature cells types (pluripotency property). In adults, stem cells, found for example in the bone marrow, have mainly a repair function in case of injury. Adult stem cells are currently used also in medical therapy; a typical example is bone marrow transplant for leukemia treatment. The major limit of using adult stem cells for medical purposes is the low availability, and the difficulty to expand them in culture maintaining their features intact. Moreover, adult stem cells have a poor regeneration range, as they are unable to differentiate into all desired cell types.Such issues were overcome thanks to the discovery of embryonic stem cells (ESCs): isolated from blastocysts, ESCs can be cultured in vitro indefinitely, and can give rise, under the appropriate conditions, to every cell type. Also, in 2006 the Nobel Prize winner Yamanaka made an astonishing discovery: somatic cells can be reprogrammed back to a stem-like state, obtaining the so-called induced pluripotent stem cells (iPSCs). ESCs and iPSCs were thought to be a great promise: many believed that their discovery would have fuelled an impressive expansion of regenerative medicine, gene therapy and personalised medicine fields in the short term, ultimately leading to the solution of many health-related problems. So far, only a part of this promise has been fulfilled, mainly because of the scarce knowledge we have about the basic biological processes that make these cells so special. In this research, we aim at improving our understanding of the molecular processes that orchestrate pluripotency focusing on beta-catenin (b-catenin), a pivotal protein in stemness maintenance. Indeed, we and others reported a central role of b-catenin in somatic cell reprogramming, differentiation, pluripotency and tissue regeneration in vivo. Still, the mechanisms through which b-catenin controls pluripotency of embryonic stem cells are highly debated.We will unfold this complexity using an interdisciplinary approach. Using cutting-edge technology, we will engineer mouse ESCs (mESCs) in which b-catenin can be modulated in a number of way (amount of protein, temporal dynamics, ability to regulate other genes). Subsequently, we will perform experiments to link specific b-catenin perturbed behaviours to mESCs self-renewal and differentiation ability. Finally, we will use potent computational approaches to understand how b-catenin interacts with other genes important for pluripotency.The project will provide a vital step of innovation and knowledge to the embryonic stem cells biology field: the results will reveal how b-catenin regulates the balance between pluripotency and differentiation, and indicate how to drive specific cell-fates in vitro.In the future, the output of the proposed project could be extended to control b-catenin dependent self-renewal and differentiation of human ESCs and iPSCs, shortening the distances between pluripotent stem cells and their applicative targets. Also, the developed techniques could be used in other biological processes in which b-catenin is involved, including development and cancer.
干细胞由两个特性定义:它们可以无限增殖产生与自身相同的细胞(自我更新特性),并且可以特化(分化)成成熟的细胞类型(多能性特性)。在成人中,干细胞,例如在骨髓中发现的干细胞,在受伤时主要具有修复功能。成体干细胞目前也用于医学治疗;治疗白血病的骨髓移植就是一个典型的例子。将成体干细胞用于医疗目的的主要限制是可获得性低,并且难以在培养中扩增并保持其特征完整。此外,成体干细胞的再生范围很差,因为它们不能分化成所有所需的细胞类型。由于胚胎干细胞(ESCs)的发现,这些问题得到了解决:从囊胚中分离出来的ESCs可以在体外无限期培养,并且可以在适当的条件下产生每种细胞类型。此外,2006年诺贝尔奖得主山中弥生有了一个惊人的发现:体细胞可以重新编程回到干细胞状态,获得所谓的诱导多能干细胞(iPSCs)。ESCs和iPSCs被认为是一个巨大的希望:许多人相信它们的发现将在短期内推动再生医学、基因治疗和个性化医学领域的令人印象深刻的扩展,最终导致许多健康相关问题的解决。到目前为止,这一承诺只实现了一部分,主要是因为我们对使这些细胞如此特殊的基本生物过程知之甚少。在这项研究中,我们的目标是提高我们对协调多能性的分子过程的理解,重点是β -连环蛋白(b-连环蛋白),这是维持干细胞的关键蛋白。事实上,我们和其他人报道了b-连环蛋白在体内体细胞重编程、分化、多能性和组织再生中的核心作用。尽管如此,b-连环蛋白控制胚胎干细胞多能性的机制仍存在高度争议。我们将使用跨学科的方法来揭示这种复杂性。利用尖端技术,我们将设计小鼠ESCs (mESCs),其中b-连环蛋白可以通过多种方式(蛋白质量,时间动态,调节其他基因的能力)进行调节。随后,我们将进行实验,将特定的b-catenin干扰行为与mESCs自我更新和分化能力联系起来。最后,我们将使用有效的计算方法来了解b-连环蛋白如何与其他多能性重要基因相互作用。该项目将为胚胎干细胞生物学领域提供创新和知识的重要一步:结果将揭示b-catenin如何调节多能性和分化之间的平衡,并指出如何在体外驱动特定的细胞命运。在未来,该项目的成果可以扩展到控制b-catenin依赖的人类ESCs和iPSCs的自我更新和分化,缩短多能干细胞与其应用靶点之间的距离。此外,开发的技术可用于b-连环蛋白参与的其他生物过程,包括发育和癌症。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Towards Engineering Biosystems with Emergent Collective Functions
迈向具有新兴集体功能的工程生物系统
- DOI:10.20944/preprints202005.0058.v1
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Gorochowski T
- 通讯作者:Gorochowski T
Control-Based Continuation: A New Approach to Prototype Synthetic Gene Networks.
- DOI:10.1021/acssynbio.1c00632
- 发表时间:2022-07-15
- 期刊:
- 影响因子:4.7
- 作者:de Cesare, Irene;Salzano, Davide;di Bernardo, Mario;Renson, Ludovic;Marucci, Lucia
- 通讯作者:Marucci, Lucia
An extended model for culture-dependent heterogenous gene expression and proliferation dynamics in mouse embryonic stem cells.
- DOI:10.1038/s41540-017-0020-5
- 发表时间:2017
- 期刊:
- 影响因子:4
- 作者:Godwin S;Ward D;Pedone E;Homer M;Fletcher AG;Marucci L
- 通讯作者:Marucci L
Control-based continuation: a new approach to prototype synthetic gene networks
基于控制的延续:原型合成基因网络的新方法
- DOI:10.1101/2021.12.21.473142
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:De Cesare I
- 通讯作者:De Cesare I
Exploring the Dynamics of Nonlinear Biochemical Systems using Control-Based Continuation
使用基于控制的延拓探索非线性生化系统的动力学
- DOI:10.1101/695866
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Gomes B
- 通讯作者:Gomes B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lucia Marucci其他文献
Lucia Marucci的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lucia Marucci', 18)}}的其他基金
21ENGBIO Reprogramming bacterial cells using whole-cell models
21ENGBIO 使用全细胞模型对细菌细胞进行重编程
- 批准号:
BB/W012235/1 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
Research Grant
COMBO: CONTROL-BASED BIODESIGN OF MAMMALIAN CELL DYNAMICS
COMBO:基于控制的哺乳动物细胞动力学生物设计
- 批准号:
EP/S01876X/1 - 财政年份:2019
- 资助金额:
$ 51.55万 - 项目类别:
Fellowship
AUTOMATIC CELL FATE ENGINEERING USING MICROFLUIDICS DEVICES
使用微流控设备进行自动细胞命运工程
- 批准号:
EP/R041695/1 - 财政年份:2018
- 资助金额:
$ 51.55万 - 项目类别:
Research Grant
AUTOMATIC CONTROL OF MAMMALIAN GENE EXPRESSION USING A MICROFLUIDIC PLATFORM
使用微流体平台自动控制哺乳动物基因表达
- 批准号:
BB/R00529X/1 - 财政年份:2017
- 资助金额:
$ 51.55万 - 项目类别:
Research Grant
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
- 批准号:82371070
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 51.55万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 51.55万 - 项目类别:
Understanding how exocrine-derived signals promote beta cell growth
了解外分泌信号如何促进 β 细胞生长
- 批准号:
10750765 - 财政年份:2024
- 资助金额:
$ 51.55万 - 项目类别:
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
项目 2:生物标志物分析、非遗传风险因素及其遗传相互作用
- 批准号:
10555697 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
Quorum Sensing Regulation of EHEC Virulence Genes
肠出血性大肠杆菌毒力基因的群体感应调控
- 批准号:
10384063 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
Epigenetically regulated stemness program and stem cell niche as targets in pediatric DIPG
表观遗传调控的干细胞程序和干细胞生态位作为儿科 DIPG 的目标
- 批准号:
10635435 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
Validation of biomarkers of infant and toddler carotenoid intake
婴幼儿类胡萝卜素摄入量生物标志物的验证
- 批准号:
10636537 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
PITPNA in pancreatic beta-cell dysfunction and diabetes pathogenesis
PITPNA 在胰腺 β 细胞功能障碍和糖尿病发病机制中的作用
- 批准号:
10636228 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:
Pyroptotic Macrophages Traps Against Shigella Infection
焦亡巨噬细胞捕获志贺氏菌感染
- 批准号:
10646015 - 财政年份:2023
- 资助金额:
$ 51.55万 - 项目类别:














{{item.name}}会员




